Clinical Trial Update: TARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating targeting dual pathways in refractory coccydynia has completed, sponsored by Istanbul University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coccydynia

Snippet

Sponsor: Istanbul University | Conditions: Coccydynia | Phase 3 | Status: COMPLETED